Clinical Trial

Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants

Name: Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants — clinical trial record (NCT07437105)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of single and multiple ascending doses of VX-272.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-01

Trial Details

NCT Number	NCT07437105
Lead Sponsor	Vertex Pharmaceuticals Incorporated
Conditions	Cystic Fibrosis
Enrollment	128 participants
Start Date	2026-02-25
Primary Completion	2027-03-23 (estimated)
Study Completion	2027-03-23 (estimated)
Updated on ClinicalTrials.gov	2026-03-31